Enliven Therapeutics, Inc. (ELVN): Weighted Average Diluted Shares
56.66M
Year ended 2025-12-31
+162.7%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 56.66M | +20.4% | 2026-03-03, From 2025-01-01 |
| 2024-12-31 | 47.07M | +32.4% | 2026-03-03, From 2024-01-01 |
| 2023-12-31 | 35.55M | n/m | 2025-03-13, From 2023-01-01 |
| 2022-12-31 | 3.12M | -85.6% | 2024-03-14, From 2022-01-01 |
| 2021-12-31 | 21.66M | n/a | 2023-02-10, From 2021-01-01 |